Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe. [electronic resource]
- The Journal of infectious diseases May 2009
- 1310-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0022-1899
10.1086/597804 doi
Acquired Immunodeficiency Syndrome--drug therapy Anti-HIV Agents--therapeutic use CD4 Lymphocyte Count CD4-Positive T-Lymphocytes--virology DNA, Complementary--genetics Drug Resistance, Viral Female HIV-1--drug effects Humans Lymphocyte Activation Mutation Nevirapine--therapeutic use RNA, Viral--genetics South Africa Viral Load Virus Latency--drug effects Zimbabwe